United Kingdom · Who invested in Immune Targeting Systems?
Immune Targeting Systems's investors include Novartis Venture Fund, Truffle Capital, London Technology Fund, HealthCap and Healthcap IX Advisor AB.
200820092010
$7.1MSeries A$13MSeries A
United Kingdom · Series A startup
Who invested in Immune Targeting Systems
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2007, from 2 sources
$7.1MSeries A$13MSeries A
- Latest round
- Series A, $13MMar 2010
- Step-upi
- 1.9×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $7.1M Jul 2007
- Biggest round
- $13M Series A · Mar 2010
- Between rounds
- 2.7 years from the last two
The rounds
- Mar 2010Series A$13M1 new3 returning
Reported by onbiovc.com
- Jul 2007Series A$7.1M4 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2007Series A2010
Novartis Venture Fund
Truffle CapitalLondon Technology Fund
HealthCap
Healthcap IX Advisor AB
Novartis Venture FundTruffle CapitalLondon Technology FundHealthCapHealthcap IX Advisor ABThe exit
ExitBuyerPriceWhen
AcquiredVaxinundisclosedFeb 2015
From historical deal records. Wrong? Tell us.
Everyone who backed them
London Technology FundVC firm2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Immune Targeting Systems
How much has Immune Targeting Systems raised?
Immune Targeting Systems has raised $20M across 2 rounds since 2007.
When did Immune Targeting Systems last raise?
Immune Targeting Systems's most recent round was a Series A of $13M in Mar 2010.
What was Immune Targeting Systems's biggest round?
Its most recent round, $13M in Mar 2010, is also its largest on record.
Who backed Immune Targeting Systems first?
Immune Targeting Systems's first round on record, in Jul 2007, was backed by Novartis Venture Fund, HealthCap and Truffle Capital and 1 others.
What stage is Immune Targeting Systems at?
Immune Targeting Systems's latest named round is a Series A, in Mar 2010.
Where is Immune Targeting Systems based?
Immune Targeting Systems is based in the United Kingdom.
Companies like Immune Targeting Systems
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.